EDF ? RWE ? EOAN ?....let's watch the stocks....
Bankia Reportedly Spain govt looking at selling a minority stake in Bankia, possibly during Q1 - press
- Spain govt would maintain its controlling stake, selling no more than 18.4% stake.
- No finalized deal terms or timing has been set as it will depend on a number of pricing and political factors.
- No finalized deal terms or timing has been set as it will depend on a number of pricing and political factors.
Potash: Hearing strength in potash being attributed to positive mention at Stifel Nicolaus; noting Uralkali raising prices
Hollande press conference just started
Journalist: are you screwing that actress?
FH: I won't answer that question
Journalist: Ok how's the economy doing?
FH: yes I'm screwing that actress
+------------------------------------------------------------------------------+
Diageo Should Bid for Beam, Consortium Offer Possible: Liberum 2014-01-14 14:19:34.945 GMT
By Gaurav Panchal Jan. 14 (Bloomberg) -- For Diageo taking control of Beam would help it prevent Pernod from becoming a stronger no. 2 (U.S., globally), Liberum analyst Pablo Zuanic says. * Diageo’s U.S., global distribution would reap greater sales synergies helping Jim Beam close gap with Jack Daniels: Liberum * A Diageo bid 10% above Suntory’s offer for Beam would be 12% EPS accretive, aassuming 3% cost of debt, 10% cost synergies * Says a Diageo-led consortium bid is quite possible * For Pernod a deal would make it a solid no. 2 in U.S., reduce reliance on Absolut there, Liberum says. * Says a Pernod bid would bring net debt/EBITDA to 5.6x and generate no EPS accretion, a rights issue could be a stretch * Jan. 13: Suntory to buy Beam for $83.50-shr cash; Ackman a holder {NSN MZCA006TTDSH <go>} * Pernod said unlikely to make counteroffer for Beam, person says {NSN MZCI316JIJVK <go>} * Dec. 2012: Suntory held talks with Diageo about a potential joint offer for Beam, Bloomberg News reported {NSN MET53S0UQVI9 <go>}
Link to Company News:{DGE LN <Equity> CN <GO>} Link to Company News:{BEAM US <Equity> CN <GO>} Link to Company News:{2587 JP <Equity> CN <GO>} Link to Company News:{RI FP <Equity> CN <GO>} Link to Company News:{REMY US <Equity> CN <GO>} Link to Company News:{CPR IM <Equity> CN <GO>} Link to Company News:{BF/B US <Equity> CN <GO>}
For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: {NH BFW<GO>}
To contact the reporter on this story: Gaurav Panchal in London at +44-20-7392-0511 or gpanchal2@bloomberg.net
To contact the editor responsible for this story: Brian Lysaght at +44-20-7330-7908 or blysaght@bloomberg.net
Delphi Automotive increases dividend 47% to $0.25 from $0.17; approves $1B buyback program (5.4% of market cap)
- Dividend payable on February 27, 2014, to shareholders of record at the close of business on February 18, 2014.
- Note: yield implied approx 1.66%
Libya national oil company indicates that the Al Sharara field has now exceeded 320K bpd in output but will not reach its 340K bpd capacity as more than 20 wells are not currently functioning
- Highlights that the Sharara oil field is unlikely to be shut by protesters as their demands were met
Danaher Corp Guides FY13 EPS at high end of prior range $0.91-0.96 v $0.95e
- Danaher announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's fourth quarter 2013 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company's fourth quarter 2013 adjusted diluted net earnings per share and core revenue growth is anticipated to be approximately at the high end of the previously announced guidance.
Gapping down
In reaction to disappointing earnings/guidance: BGFV -4.4%, SSYS -4.1% (also was initiated with a Outperform at RBC Capital Mkts), BBW -2.9% (ticking lower), WWW -2.5% (sees FY13 EPS at high end of $1.37-1.42 vs $1.42 Capital IQ Consensus Estimate; sees revs $2.69 bln vs $2.72 bln Capital IQ Consensus Estimate), DAN -1.8%, YUM -0.7%, (reports Dec SSS increased 2% y/y for China division), WFC -0.5%.
Metals/mining stocks trading lower: HMY -3.3%, GFI -3%, IAG -2.1%, VALE -1.1%, GDX -1.1%, AU -1.1%, GOLD -0.9%, GLD -0.5%.
3D printing names are lower following SSYS guidance: DDD -4.2% ( initiated with a Outperform at RBC Capital Mkts), VJET -2.6%, XONE -2.4%
Other news: APU -5.2% (Heritage ETC, an affiliate of Energy Transfer Partners (ETP), to offer 8 mln AmeriGas common units), RAS -3.2% (announces 10 mln common share offering), WDAY -2.1% (announces proposed follow-on offering of 6 mln shares), FULL -1.7% (announces public offering of 1.6 mln shares of common stock), DDD -1.7% (still checking), GNW -1.5% (still checking), IHS-1% (announces 3.478 mln share secondary offering of common stock by Conscientia Investment Ltd), ALNY -0.5% (Isis Pharmaceuticals to Receive $7.5 Million from Alnylam).
Analyst comments: WU -2.9% (downgraded to Sell from Neutral at Citigroup), RTEC -2% ( downgraded to Neutral from Outperform at Credit Suisse), QCOM -1.3% (downgraded to Market Perform from Outperform at Raymond James), GIS -1.2% (downgraded to Underweight from Equal Weight at Morgan Stanley), CAM -1.1% (downgraded to Equal Weight from Overweight at Morgan Stanley ), SIRI -0.8% (downgraded to Equal Weight from Overweight at Barclays ), MSFT -0.8% (Microsoft downgraded to Neutral from Buy at Citigroup)
Metals/mining stocks trading lower: HMY -3.3%, GFI -3%, IAG -2.1%, VALE -1.1%, GDX -1.1%, AU -1.1%, GOLD -0.9%, GLD -0.5%.
3D printing names are lower following SSYS guidance: DDD -4.2% ( initiated with a Outperform at RBC Capital Mkts), VJET -2.6%, XONE -2.4%
Other news: APU -5.2% (Heritage ETC, an affiliate of Energy Transfer Partners (ETP), to offer 8 mln AmeriGas common units), RAS -3.2% (announces 10 mln common share offering), WDAY -2.1% (announces proposed follow-on offering of 6 mln shares), FULL -1.7% (announces public offering of 1.6 mln shares of common stock), DDD -1.7% (still checking), GNW -1.5% (still checking), IHS-1% (announces 3.478 mln share secondary offering of common stock by Conscientia Investment Ltd), ALNY -0.5% (Isis Pharmaceuticals to Receive $7.5 Million from Alnylam).
Analyst comments: WU -2.9% (downgraded to Sell from Neutral at Citigroup), RTEC -2% ( downgraded to Neutral from Outperform at Credit Suisse), QCOM -1.3% (downgraded to Market Perform from Outperform at Raymond James), GIS -1.2% (downgraded to Underweight from Equal Weight at Morgan Stanley), CAM -1.1% (downgraded to Equal Weight from Overweight at Morgan Stanley ), SIRI -0.8% (downgraded to Equal Weight from Overweight at Barclays ), MSFT -0.8% (Microsoft downgraded to Neutral from Buy at Citigroup)
Gapping up
In reaction to strong earnings/guidance: QTM +19.7%, LEDS +19.5% (light volume), DRWI +12.6%, NLS +12.2% (sees Q4 EPS and revs above consensus), BHE +3.1%, HLS +1.8% (discloses preliminary observations and considerations on the quarter; increases 2013 guidance), TLYS +1.4% (expects fourth quarter results to be in the mid range of our previously communicated outlook for both comparable store sales and earnings), JPM +0.5%.
M&A news: ANV +25.6% (China Gold Stone Mining Reports Cash Tender Bid for Allied Nevada Shares, tendering holders will be paid $7.50/share in cash), CHTR +1.7% / TWC +1.6%(Charter offers to buy TWC for about $132.50 per share; Time Warner Cable unanimously rejects 3rd proposal from Charter).
A few financial related names seeing modest strength: IRE +2.4%, ING +1.9%, DB +1%, BAC +0.5% .
Select oil/gas related names trading higher: CHK +4.1%, QEP +2.8% (JANA Partners discloses 9.5% active stake in amended 13D filing out last night; up from 7.6% last reported on 11/13; will continue to have discussions with the board), HK +1.9%, STO +1.4%, RIG +1.3%, RDS.A +0.6%, BP +0.5%, TOT +0.1%, .
Other news: OPTT +59.1% (announces funding agreement with Australian Government for A$66.5 mln Grant), TNK +9.2% (CEO Bruce Chan announces intention to resign effective June 20, 2014; a search will be conducted for his replacement), GALE +6.2% (Galena Biopharma and Dr. Reddy's (RDY) Announce Strategic Partnership for NeuVax in India), DM +5.6% (anounced that it entered into the Seventh Amendment to its Third Amended and Restated Credit Agreement dated December 6, 2010 ), +4.2% (still checking), TSU +3.3% (still checking), PLUG +3.3% (continued strength), STM +2.8% (still checking), ARIA +2.8% (Ariad Pharm and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease; triggers milestone payments to ARIAD of $3.75 ml), CTIC +2.7% (provides 2014 outlook and recent drug portfolio progres), JNPR +2.7% (Juniper Networks comments on Elliott's 13D filing), FLR +2.6% (Fluor and JGC awarded EPC contract for Kitimat LNG project), ARMH +2.4% (still checking), VVUS +2.3% (Vivus Collaborates with Aetna to test first comprehensive weight management program integrating weight loss medication), CTB +2.1% (provides update on its Chinese JV), GOOG +1.5% ( to acquire Nest Labs ), UN +1.5% (still checking), WEN +1.3% (announces commencement of a modified 'Dutch auction' tender offer to repurchase shares of its common stock for an aggregate purchase price of up to $275.0 mln ), JNPR +1.1% (comments on Elliott's 13D filing), MCK +1.1% (may consider Celesio JV, according to reports ), YRCW +0.8% (Rima Senvest Management disclosed 6.8% passive stake in 13G filing out last night after the close; downgraded to Hold from Buy at BB&T Capital Mkts ), SHLD +0.7% (modestly rebounding despite S&P putting Sears Holdings Corp. Ratings on CreditWatch Negative on Lower Earnings Expectations; expect cash burn to be more than anticipated), FINL +0.4% and HRB +0.4% (positive commentary on Mad Money), PDCE +0.3% (S.A.C. Capital Advisors discloses 5.1% passive stake in 13G filing).
Analyst comments: TC +22.7% (upgraded to Buy from Neutral at BofA/Merrill ), TSRO +6.5% (attributed to positive Deutsche Bank comments), LOGI +3.4% (upgraded to Buy from Neutral at Goldman ), AZN +3% (upgraded to Outperform from Market Perform at Leerink), CLF +2.9% (upgraded to Buy from Hold at Deutsche Bank), BRCD +2.8% (upgraded to Overweight from Neutral at JP Morgan), PAY +2.2% (upgraded to Overweight from Neutral at JPMorgan), INTC +2% (upgraded to Overweight from Neutral at JP Morgan), YHOO +1% (upgraded to Buy from Fair Value at CRT Capital )
M&A news: ANV +25.6% (China Gold Stone Mining Reports Cash Tender Bid for Allied Nevada Shares, tendering holders will be paid $7.50/share in cash), CHTR +1.7% / TWC +1.6%(Charter offers to buy TWC for about $132.50 per share; Time Warner Cable unanimously rejects 3rd proposal from Charter).
A few financial related names seeing modest strength: IRE +2.4%, ING +1.9%, DB +1%, BAC +0.5% .
Select oil/gas related names trading higher: CHK +4.1%, QEP +2.8% (JANA Partners discloses 9.5% active stake in amended 13D filing out last night; up from 7.6% last reported on 11/13; will continue to have discussions with the board), HK +1.9%, STO +1.4%, RIG +1.3%, RDS.A +0.6%, BP +0.5%, TOT +0.1%, .
Other news: OPTT +59.1% (announces funding agreement with Australian Government for A$66.5 mln Grant), TNK +9.2% (CEO Bruce Chan announces intention to resign effective June 20, 2014; a search will be conducted for his replacement), GALE +6.2% (Galena Biopharma and Dr. Reddy's (RDY) Announce Strategic Partnership for NeuVax in India), DM +5.6% (anounced that it entered into the Seventh Amendment to its Third Amended and Restated Credit Agreement dated December 6, 2010 ), +4.2% (still checking), TSU +3.3% (still checking), PLUG +3.3% (continued strength), STM +2.8% (still checking), ARIA +2.8% (Ariad Pharm and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease; triggers milestone payments to ARIAD of $3.75 ml), CTIC +2.7% (provides 2014 outlook and recent drug portfolio progres), JNPR +2.7% (Juniper Networks comments on Elliott's 13D filing), FLR +2.6% (Fluor and JGC awarded EPC contract for Kitimat LNG project), ARMH +2.4% (still checking), VVUS +2.3% (Vivus Collaborates with Aetna to test first comprehensive weight management program integrating weight loss medication), CTB +2.1% (provides update on its Chinese JV), GOOG +1.5% ( to acquire Nest Labs ), UN +1.5% (still checking), WEN +1.3% (announces commencement of a modified 'Dutch auction' tender offer to repurchase shares of its common stock for an aggregate purchase price of up to $275.0 mln ), JNPR +1.1% (comments on Elliott's 13D filing), MCK +1.1% (may consider Celesio JV, according to reports ), YRCW +0.8% (Rima Senvest Management disclosed 6.8% passive stake in 13G filing out last night after the close; downgraded to Hold from Buy at BB&T Capital Mkts ), SHLD +0.7% (modestly rebounding despite S&P putting Sears Holdings Corp. Ratings on CreditWatch Negative on Lower Earnings Expectations; expect cash burn to be more than anticipated), FINL +0.4% and HRB +0.4% (positive commentary on Mad Money), PDCE +0.3% (S.A.C. Capital Advisors discloses 5.1% passive stake in 13G filing).
Analyst comments: TC +22.7% (upgraded to Buy from Neutral at BofA/Merrill ), TSRO +6.5% (attributed to positive Deutsche Bank comments), LOGI +3.4% (upgraded to Buy from Neutral at Goldman ), AZN +3% (upgraded to Outperform from Market Perform at Leerink), CLF +2.9% (upgraded to Buy from Hold at Deutsche Bank), BRCD +2.8% (upgraded to Overweight from Neutral at JP Morgan), PAY +2.2% (upgraded to Overweight from Neutral at JPMorgan), INTC +2% (upgraded to Overweight from Neutral at JP Morgan), YHOO +1% (upgraded to Buy from Fair Value at CRT Capital )